Live Breaking News & Updates on Associate Professor Mark Coulthard

Stay updated with breaking news from Associate professor mark coulthard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UniQuest partners with CSL to develop potential new therapy


Share
A potential therapy developed at The University of Queensland may one day save lives by helping patients recover faster from severe trauma, extensive burns and major surgery.
UniQuest, UQ’s technology transfer company, has partnered with global biotechnology company CSL to accelerate the development of a potential treatment for the repair of blood vessels damaged by inflammation.
Dr Coulthard said the technology could benefit critically ill patients with sepsis or acute respiratory distress syndrome, as well as improve patient recovery from heart attack, stroke and organ transplant.
“It may also prevent high-risk patients from developing Systemic Inflammatory Response Syndrome (SIRS), which affects more than half of critically ill patients and contributes to significant mortality and morbidity,” Dr Coulthard said. ....

Trent Woodruff , Perry Bartlett , Mark Coulthard , Nemat Khan , Andrew Boyd , Head Of Global Research Innovation Marthe Dombrain , School Of Biomedical Sciences , Queensland Brain Institute , University Of Queensland , Research Acceleration Initiative , Associate Professor Mark Coulthard , Queensland Children , Professor Trent Woodruff , Biomedical Sciences , Systemic Inflammatory Response Syndrome , Professor Andrew Boyd , Emeritus Professor Perry Bartlett , Queensland Brain , Dean Moss , Global Research Innovation Marthed Ombrain , Acceleration Initiative , ட்ரெண்ட் வூட்ரஃப் , பெர்ரி பார்ட்லெட் , குறி கூல்ட்ஹார்ட் , நேமாத் காந் , ஆண்ட்ரூ பையன் ,

Two QIMR Berghofer scientists awarded CSL Research Acceleration Initiative partnerships


Date Time
Two QIMR Berghofer scientists awarded CSL Research Acceleration Initiative partnerships
Two QIMR Berghofer scientists will collaborate with leading global biotechnology company CSL on new immunological targets after being awarded Research Acceleration Initiative partnerships.
The head of the Immunology and Infection Laboratory, Professor Christian Engwerda, and the head of the Molecular Immunology Laboratory, Associate Professor Michelle Wykes, will each receive $500,000 over two years to conduct collaborative research projects with CSL.
As well as the funding, the partnerships also give the researchers access to CSL’s R&D experts.
CSL has awarded four partnerships nationally, with QIMR Berghofer receiving half of those. ....

Christian Engwerda , Trent Woodruff , Mark Coulthard , Marthe Dombrain , Michelle Wykes , Fabienne Mackay , Molecular Immunology Laboratory , Head Of Global Research Innovation , University Of Queensland , Infection Laboratory , Research Acceleration Initiative , University Of Western Australia , Professor Christian Engwerda , Associate Professor Michelle Wykes , Global Research Innovation , Marthed Ombrain , Acceleration Initiative , Professor Wykes , Professor Fabienne Mackay , Professor Livia Hool , Western Australia , Associate Professor Mark Coulthard , Professor Trent Woodruff , Qimr Berghofer , Medical Research , Western Australia ,